The life and times of cellular senescence in skeletal muscle: friend or foe for homeostasis and adaptation?

A gradual decline in skeletal muscle mass and function is closely tied to increased mortality and disease risk during organismal aging. Exercise training is the most effective way to enhance muscle health, but the adaptive response to exercise as well as muscle repair potential is blunted in older individuals. Numerous mechanisms contribute to the loss of muscle mass and plasticity as aging progresses. An emerging body of recent evidence implicates an accumulation of senescent ("zombie") cells in muscle as a contributing factor to the aging phenotype. Senescent cells cannot divide but can release inflammatory factors and create an unfavorable environment for homeostasis and adaptation. On balance, some evidence suggests that cells with senescent characteristics can be beneficial for the muscle adaptive process, specifically at younger ages. Emerging evidence also suggests multinuclear post-mitotic muscle fibers could become senescent. In this review, we summarize current literature on the prevalence of senescent cells in skeletal muscle and highlight the consequences of senescent cell removal on muscle mass, function, and adaptability. We examine key limitations in the field of senescence specifically in skeletal muscle and identify areas of research that require future investigation.

[1]  A. Dopazo,et al.  Senescence atlas reveals an aged-like inflamed niche that blunts muscle regeneration , 2022, Nature.

[2]  N. LeBrasseur,et al.  p21 induces a senescence program and skeletal muscle dysfunction , 2022, Molecular metabolism.

[3]  J. McCarthy,et al.  Skeletal Muscle Nuclei in Mice are not Post-mitotic , 2022, bioRxiv.

[4]  J. Huard,et al.  Senolytic elimination of senescent macrophages restores muscle stem cell function in severely dystrophic muscle , 2022, Aging.

[5]  L. Lerman,et al.  Cellular senescence: the good, the bad and the unknown , 2022, Nature Reviews Nephrology.

[6]  Ian R. Lanza,et al.  Characterization of cellular senescence in aging skeletal muscle , 2022, Nature Aging.

[7]  Kevin A. Murach,et al.  Senolytic treatment rescues blunted muscle hypertrophy in old mice , 2022, GeroScience.

[8]  J. Markworth,et al.  Removal of p16 INK4 Expressing Cells in Late Life has Moderate Beneficial Effects on Skeletal Muscle Function in Male Mice , 2022, Frontiers in Aging.

[9]  L. Niedernhofer,et al.  Targeting cellular senescence with senotherapeutics: senolytics and senomorphics , 2022, The FEBS journal.

[10]  Kevin A. Murach,et al.  Deletion of SA β‐Gal+ cells using senolytics improves muscle regeneration in old mice , 2021, Aging cell.

[11]  N. LeBrasseur,et al.  A new gene set identifies senescent cells and predicts senescence-associated pathways across tissues , 2021, Nature Communications.

[12]  N. LeBrasseur,et al.  Skeletal muscle aging, cellular senescence, and senotherapeutics: Current knowledge and future directions , 2021, Mechanisms of Ageing and Development.

[13]  Kevin A. Murach,et al.  Nucleus Type-Specific DNA Methylomics Reveals Epigenetic “Memory” of Prior Adaptation in Skeletal Muscle , 2021, Function.

[14]  Chih-Yang Huang,et al.  Reduced stem cell aging in exercised human skeletal muscle is enhanced by ginsenoside Rg1 , 2021, Aging.

[15]  Brian R. Kotajarvi,et al.  Exercise reduces circulating biomarkers of cellular senescence in humans , 2021, Aging cell.

[16]  Michel G. Arsenault,et al.  Loss of dystrophin expression in skeletal muscle is associated with senescence of macrophages and endothelial cells. , 2021, American journal of physiology. Cell physiology.

[17]  Je-Jung Lee,et al.  HMGB1 orchestrates STING-mediated senescence via TRIM30α modulation in cancer cells , 2021, Cell Death Discovery.

[18]  J. Rodríguez-León,et al.  Is Senescence-Associated β-Galactosidase a Reliable in vivo Marker of Cellular Senescence During Embryonic Development? , 2021, Frontiers in Cell and Developmental Biology.

[19]  D. Baker,et al.  Cellular senescence in ageing: from mechanisms to therapeutic opportunities , 2020, Nature Reviews Molecular Cell Biology.

[20]  J. Gil,et al.  Senescence and the SASP: many therapeutic avenues , 2020, Genes & development.

[21]  K. Gundersen,et al.  Myonuclear content regulates cell size with similar scaling properties in mice and humans , 2020, Nature Communications.

[22]  I. Nishino,et al.  Cellular senescence-mediated exacerbation of Duchenne muscular dystrophy , 2020, Scientific Reports.

[23]  Kevin A. Murach,et al.  Muscle memory: myonuclear accretion, maintenance, morphology, and miRNA levels with training and detraining in adult mice , 2020, Journal of cachexia, sarcopenia and muscle.

[24]  J. Kirkland,et al.  Senolytic drugs: from discovery to translation , 2020, Journal of internal medicine.

[25]  D. Sheppard,et al.  Sentinel p16INK4a+ cells in the basement membrane form a reparative niche in the lung , 2020, bioRxiv.

[26]  Yu Cao,et al.  Linking skeletal muscle aging with osteoporosis by lamin A/C deficiency , 2020, PLoS biology.

[27]  D. Gewirtz,et al.  Therapy-Induced Senescence: An “Old” Friend Becomes the Enemy , 2020, Cancers.

[28]  T. von Zglinicki,et al.  Senescence in Post-Mitotic Cells: A Driver of Aging? , 2020, Antioxidants & redox signaling.

[29]  M. Fujimiya,et al.  Exercise enhances skeletal muscle regeneration by promoting senescence in fibro-adipogenic progenitors , 2020, Nature Communications.

[30]  P. Robbins,et al.  Tissue specificity of senescent cell accumulation during physiologic and accelerated aging of mice , 2020, Aging cell.

[31]  M. Masternak,et al.  Dasatinib plus quercetin prevents uterine age-related dysfunction and fibrosis in mice , 2020, Aging.

[32]  C. Schmitt,et al.  Cellular Senescence: Defining a Path Forward , 2019, Cell.

[33]  J. McCarthy,et al.  "Muscle Memory" Not Mediated By Myonuclear Number?: Secondary Analysis of Human Detraining Data. , 2019, Journal of applied physiology.

[34]  H. Holmberg,et al.  Effects of training, detraining, and retraining on strength, hypertrophy, and myonuclear number in human skeletal muscle. , 2019, Journal of applied physiology.

[35]  G. Enikolopov,et al.  Obesity-Induced Cellular Senescence Drives Anxiety and Impairs Neurogenesis , 2019, Cell metabolism.

[36]  Kevin A. Murach,et al.  Elevated myonuclear density during skeletal muscle hypertrophy in response to training is reversed during detraining. , 2019, American journal of physiology. Cell physiology.

[37]  M. Gorospe,et al.  Senolytic therapy alleviates Aβ-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer’s disease model , 2019, Nature Neuroscience.

[38]  M. Jensen,et al.  Targeting senescent cells alleviates obesity‐induced metabolic dysfunction , 2019, Aging cell.

[39]  B. Dong,et al.  Skeletal Muscle Mass as a Mortality Predictor among Nonagenarians and Centenarians: A Prospective Cohort Study , 2019, Scientific Reports.

[40]  Laura C. Greaves,et al.  Length‐independent telomere damage drives post‐mitotic cardiomyocyte senescence , 2019, The EMBO journal.

[41]  G. Nelson,et al.  The bystander effect contributes to the accumulation of senescent cells in vivo , 2018, Aging cell.

[42]  Frédérick A. Mallette,et al.  Cellular Senescence in Postmitotic Cells: Beyond Growth Arrest. , 2018, Trends in cell biology.

[43]  M. Demaria,et al.  Hallmarks of Cellular Senescence. , 2018, Trends in cell biology.

[44]  D. Allison,et al.  Senolytics Improve Physical Function and Increase Lifespan in Old Age , 2018, Nature Medicine.

[45]  P. Robbins,et al.  Senotherapeutics for healthy ageing , 2018, Nature Reviews Drug Discovery.

[46]  Sang-Man Jin,et al.  Increase in relative skeletal muscle mass over time and its inverse association with metabolic syndrome development: a 7-year retrospective cohort study , 2018, Cardiovascular Diabetology.

[47]  S. Gollnick,et al.  p16(Ink4a) and senescence-associated β-galactosidase can be induced in macrophages as part of a reversible response to physiological stimuli , 2017, Aging.

[48]  N. LeBrasseur,et al.  Targeting cellular senescence prevents age-related bone loss in mice , 2017, Nature Medicine.

[49]  J. Kirkland,et al.  Cellular Senescence: A Translational Perspective , 2017, EBioMedicine.

[50]  J. Passos,et al.  Telomeres and Cell Senescence - Size Matters Not , 2017, EBioMedicine.

[51]  L. Fiette,et al.  Injury-Induced Senescence Enables In Vivo Reprogramming in Skeletal Muscle. , 2017, Cell stem cell.

[52]  J. Tidball Regulation of muscle growth and regeneration by the immune system , 2017, Nature Reviews Immunology.

[53]  A. Gudkov,et al.  Aging of mice is associated with p16(Ink4a)- and β-galactosidase-positive macrophage accumulation that can be induced in young mice by senescent cells , 2016, Aging.

[54]  A. Pezeshki,et al.  Naturally occurring p16Ink4a-positive cells shorten healthy lifespan , 2016, Nature.

[55]  J. Hoeijmakers,et al.  An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA. , 2014, Developmental cell.

[56]  E. Ballestar,et al.  Geriatric muscle stem cells switch reversible quiescence into senescence , 2014, Nature.

[57]  W. Wood,et al.  Mice Fed Rapamycin Have an Increase in Lifespan Associated with Major Changes in the Liver Transcriptome , 2014, PloS one.

[58]  K. Gundersen,et al.  A cellular memory mechanism aids overload hypertrophy in muscle long after an episodic exposure to anabolic steroids , 2013, The Journal of physiology.

[59]  S. Schiaffino,et al.  Muscle type and fiber type specificity in muscle wasting. , 2013, The international journal of biochemistry & cell biology.

[60]  B. Chazaud,et al.  Monocyte/macrophage interactions with myogenic precursor cells during skeletal muscle regeneration , 2013, The FEBS journal.

[61]  J. Bartek,et al.  Specific lipofuscin staining as a novel biomarker to detect replicative and stress-induced senescence. A method applicable in cryo-preserved and archival tissues , 2012, Aging.

[62]  D. Baker,et al.  Reduced Life- and Healthspan in Mice Carrying a Mono-Allelic BubR1 MVA Mutation , 2012, PLoS genetics.

[63]  Ming-Yu Yang,et al.  Induction of Cellular Senescence by Doxorubicin Is Associated with Upregulated miR-375 and Induction of Autophagy in K562 Cells , 2012, PloS one.

[64]  J. Sanes,et al.  Shared Resistance to Aging and ALS in Neuromuscular Junctions of Specific Muscles , 2012, PloS one.

[65]  N. LeBrasseur,et al.  Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders , 2011, Nature.

[66]  N. Schaum,et al.  p53-dependent release of Alarmin HMGB1 is a central mediator of senescent phenotypes , 2011, The Journal of cell biology.

[67]  K. Gundersen,et al.  Myonuclei acquired by overload exercise precede hypertrophy and are not lost on detraining , 2010, Proceedings of the National Academy of Sciences.

[68]  J. Campisi,et al.  The senescence-associated secretory phenotype: the dark side of tumor suppression. , 2010, Annual review of pathology.

[69]  Marco Pahor,et al.  Rapamycin fed late in life extends lifespan in genetically heterogeneous mice , 2009, Nature.

[70]  Anindya Dutta,et al.  p21 in cancer: intricate networks and multiple activities , 2009, Nature Reviews Cancer.

[71]  G. Nelson,et al.  DNA damage response and cellular senescence in tissues of aging mice , 2009, Aging cell.

[72]  M. Nordin,et al.  Effects of aging on Type II muscle fibers: a systematic review of the literature. , 2007, Journal of aging and physical activity.

[73]  Jessie C. Jeyapalan,et al.  Accumulation of senescent cells in mitotic tissue of aging primates , 2007, Mechanisms of Ageing and Development.

[74]  R. Kumar,et al.  BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice , 2004, Nature Genetics.

[75]  Zhong-xiang Lin,et al.  Cisplatin-induced premature senescence with concomitant reduction of gap junctions in human fibroblasts , 2004, Cell Research.

[76]  N. Carter,et al.  A DNA damage checkpoint response in telomere-initiated senescence , 2003, Nature.

[77]  J. DiMaio,et al.  p21 is essential for normal myogenic progenitor cell function in regenerating skeletal muscle. , 2003, American journal of physiology. Cell physiology.

[78]  I. Roninson,et al.  Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[79]  S. Elledge,et al.  p21(CIP1) and p57(KIP2) control muscle differentiation at the myogenin step. , 1999, Genes & development.

[80]  A. Brenner,et al.  Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivation , 1998, Oncogene.

[81]  C B Harley,et al.  Replicative Senescence and Cell Immortality: The Role of Telomeres and Telomerase , 1997, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[82]  C Roskelley,et al.  A biomarker that identifies senescent human cells in culture and in aging skin in vivo. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[83]  G. Hannon,et al.  Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD , 1995, Science.

[84]  C. J. Roberts,et al.  Lipid Deposition in Different Fiber Types of Skeletal Muscle of Periparturient Dairy Cows , 1983, Veterinary pathology.

[85]  H. A. Padykula,et al.  CYTOLOGICAL STUDIES OF FIBER TYPES IN SKELETAL MUSCLE , 1966, The Journal of cell biology.